Newer tetracycline derivatives: Synthesis, anti-HIV, antimycobacterial activities and inhibition of HIV-1 integrase

被引：36

作者：

Sriram, Dharmarajan ^{[1
]}

Yogeeswari, Perumal ^{[1
]}

Senchani, Geetha ^{[1
]}

Banerjee, Debjani ^{[1
]}

机构：

[1] Birla Inst Technol & Sci, Pharm Grp, Med Chem Res Lab, Pilani 333031, Rajasthan, India

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2007年 / 17卷 / 08期

关键词：

tetracycline derivatives; anti-HIV activity; antimycobacterial activity; HIV-1; integrase; SPECTRUM CHEMOTHERAPEUTIC PROPERTIES; HUMAN-IMMUNODEFICIENCY-VIRUS; TUBERCULOSIS; MORTALITY;

D O I：

10.1016/j.bmcl.2006.11.055

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of new tetracycline derivatives has been synthesized by reacting appropriate tetracyclines, formaldehyde and secondary amino (piperazino) function of fluoroquinolones using microwave irradiation with the yield ranging from 41 evaluated for its anti-HIV, antimycobacterial activities and HIV-1 integrase (IN) enzyme inhibition studies. Among the synthesized compounds, compound 10 was found to be the most promising compound active against HIV-1 replication with EC50 of 5.2 mu M and was nontoxic to the CEM cells untill 200 mu M, and MIC of 0.2 mu g/mL against Mycobacterium tuberculosis, with moderate inhibition of both 3'-processing and strand transfer steps of HIV-1 IN. (c) 2007 Published by Elsevier Ltd.

引用

页码：2372 / 2375

页数：4

共 15 条

[1] HIV-1 integrase: Structural organization, conformational changes, and catalysis [J].

Asante-Appiah, E ;

Skalka, AM .

ADVANCES IN VIRUS RESEARCH, VOL 52, 1999, 52 :351-369

[2] AN OUTBREAK OF TUBERCULOSIS WITH ACCELERATED PROGRESSION AMONG PERSONS INFECTED WITH THE HUMAN-IMMUNODEFICIENCY-VIRUS - AN ANALYSIS USING RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISMS [J].

DALEY, CL ;

SMALL, PM ;

SCHECTER, GF ;

SCHOOLNIK, GK ;

MCADAM, RA ;

JACOBS, WR ;

HOPEWELL, PC .

NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (04) :231-235

[3] New approaches toward anti-HIV chemotherapy [J].

De Clercq, E .

JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (05) :1297-1313

[4] Global burden of tuberculosis - Estimated incidence, prevalence, and mortality by country [J].

Dye, C ;

Scheele, S ;

Dolin, P ;

Pathania, V ;

Raviglione, RC .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :677-686

[5] HIV integrase structure and function [J].

Esposito, D ;

Craigie, R .

ADVANCES IN VIRUS RESEARCH, VOL 52, 1999, 52 :319-333

[6]

Mazumder A, 2000, METH MOLEC MED, V24, P327, DOI 10.1385/1-59259-245-7:327

[7]

Mitsuya H., 1999, TXB AIDS MED, P751

[8]

*NAT COMM CLIN LAB, 1990, M24P NAT COMM CLIN L

[9] Potent inhibitors of human immunodeficiency virus type 1 integrase: Identification of a novel four-point pharmacophore and tetracyclines as novel inhibitors [J].

Neamati, N ;

Hong, HX ;

Sunder, S ;

Milne, GWA ;

Pommier, Y .

MOLECULAR PHARMACOLOGY, 1997, 52 (06) :1041-1055

[10] Integrase inhibitors to treat HIV/AIDS [J].

Pommier, Y ;

Johnson, AA ;

Marchand, C .

NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (03) :236-248

← 1 2 →